Focus: Flosonics develops wireless wearable hemodynamic monitoring devices using non-invasive ultrasound technology, positioning itself in the specialized medical device and biotech space. The company is early-stage with minimal publicly available financial data and a small active job count of 3 roles.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
2 added, 1 removed. Backfill posture.
Flosonics represents a high-risk, high-reward early-stage biotech opportunity best suited for candidates seeking startup equity exposure and willing to tolerate significant uncertainty around financing and timelines.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Flosonics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Flosonics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles